Summary Merck & Co has announced a deal with King’s College London (KCL) and Wellcome to investigate a new class of painkillers…
ChemRobotics Pvt. Ltd. © 2023, All Rights Reserved.
Designed and Developed by Ample eBusiness
Tag:
Drug
-
-
Alembic PharmaRegulatoryU.S FDA
Alembic Pharmaceuticals bags USFDA nod for Macitentan tablets
by adminby adminSummary : Alembic Pharmaceuticals received a tentative approval from the United States Food & Drug Administration (USFDA) for its Abbreviated New Drug…
-
Pharma Science & ResearchSanofi Inc.
Nirsevimab first potential immunisation to protect against RSV in infants
by adminby adminSynopsis : Nirsevimab has the potential to offer RSV protection for all infants, with a single dose showing 74.5 percent efficacy in…
-
Boehringer Ingelheim
Boehringer Ingelheim and OSE Immunotherapeutics To Present Biomarker Analyses from the Phase 1 Clinical Trial with First-in-Class SIRPα Inhibitor BI 765063 in Advanced Solid Tumors
by adminby adminSummary : OSE Immunotherapeutics (ISIN: FR0012127173; Mnemo: OSE), today announced that early biomarker analyses from the ongoing Phase 1 clinical trial with SIRPα…
-
CompaniesIntellectual Property (IP)Patent LitigationPatentsPfizerWest-Coast Pharmaceutical works Ltd
Pfizer Inc filed a Patent Infringement suit against West-Coast Pharmaceutical works Ltd.
by adminby adminSummary : Pfizer Inc. (plaintiff) filed a patent infringement suit against West-Coast Pharmaceutical works Ltd. (defendant) for inviting manufacturers to contract with…
-
Global MarketMerger / Acquisition
SeQuent Scientific acquires Brazil-based animal drug firm for $5 million
by adminby adminSummary : PE firm Carlyle-backed SeQuent Scientific has acquired 100% stake in Brazil-based Nourrie Sade e Nutrio Animal Ltd for $5mn (Rs36.2cr),…
-
AbbVieCompaniesMerger / Acquisition
AbbVie Bolsters Neuro Platform with $1B Syndesi Buy
by adminby adminSummary : AbbVie has bolstered its neuropsychiatric and neurodegenerative portfolio with the acquisition of Belgium-based Syndesi Therapeutics in a deal valued at…
-
EuropePharma Science & Research
NICE recommends cenobamate for treatment of adult epilepsy patients in UK
by adminby adminSummary : NICE has issued a positive recommendation for Arvelle Therapeutics’ cenobamate (Ontozry), for the treatment of focal-onset seizures in adults with…
-
RegulatoryU.S FDA
GC Pharma Receives Complete Response Letter From the U.S. FDA For ‘ALYGLO’
by adminby adminSummary : GC Pharma (KRX:006280) today announced that it has received a Complete Response Letter (CRL) from the U.S. Food and Drug…
-
AbbVieCompaniesGlobal MarketPharma Science & Research
AbbVie Makes Moves to Increase Profits in 2022
by adminby adminSummary : Chicago-based AbbVie has been making major decisions with company-wide impacts. The therapeutic company appears to be making changes that will…